Organization Overview
Alternative names
acellular pertussis vaccine (including diptheria and tetanus toxoids) (Tripedia) (1 trial)
acetylsalicylic acid (aspirin) (27 trials)
aldesleukin (Proleukin) (223 trials)
anastrozole (arimidex) (30 trials)
beta carotene (solatene) (3 trials)
bupivacaine (Exparel) (3 trials)
bupropion (wellbutrin) (14 trials)
carbamazepine (tegretol) (1 trial)
denileukin diftitox (ontak) (14 trials)
dexmedetomidine (precedex) (5 trials)
duloxetine (Cymbalta) (5 trials)
exemestane (aromasin) (29 trials)
Fluciclovine (Axumin) (13 trials)
fluorouracil (efudex) (342 trials)
gabapentin (neurontin) (9 trials)
gadobenate (Multihance) (7 trials)
gadoxetate disodium (eovist) (4 trials)
hpv 16/18 vaccine (Cervarix) (4 trials)
human papillomavirus 9-valent vaccine, recombinant (Gardasil 9) (10 trials)
hydromorphone (diladid) (2 trials)
indinavir (crixivan) (4 trials)
letrozole (femara) (51 trials)
leuprolide (lupron) (53 trials)
levetiracetam (keppra) (3 trials)
magnesium sulfate (Tis-U-Sol) (5 trials)
methylphenidate (ritalin) (8 trials)
naltrexone (revia) (249 trials)
nicotine (nicorette) (80 trials)
oxaliplatin (eloxatin) (227 trials)
oxcarbazepine (trileptal) (1 trial)
oxycodone (oxycontin) (5 trials)
perampanel (fycompa) (2 trials)
perflutren protein-type a microspheres (Optison) (9 trials)
phenobarbital (Luminal) (2 trials)
progesterone (progestasert) (2 trials)
relugolix (ORGOVYX) (4 trials)
saquinavir (invirase) (2 trials)
sofosbuvir (sovaldi) (1 trial)
tamoxifen (nolvadex) (69 trials)
topiramate (topamax) (1 trial)
toremifene (fareston) (2 trials)
trastuzumab (herceptin) (124 trials)
valproic acid (depakene) (14 trials)
varenicline (chantix) (21 trials)
131i-lipiodol (Lipiodol) (1 trial)
64cu-dota-daratumumab (2 trials)
abiraterone (zytiga) (26 trials)
acetaminophen (tylenol) (5 trials)
aciclovir (zovirax) (3 trials)
afatinib (gilotrif) (8 trials)
alendronic acid (fosamax) (3 trials)
allogeneic blood cells (3 trials)
allogeneic bone marrow (29 trials)
allogeneic cord blood (8 trials)
allogeneic hematopoietic stem cells (Hemacord) (193 trials)
allogeneic stem cells (7 trials)
alpha-1 antitrypsin (Prolastin) (3 trials)
amifostine (ethyol) (34 trials)
amitriptyline (elavil) (2 trials)
amphotericin b (fungizone) (1 trial)
anidulafungin (eraxis) (2 trials)
Anti-thymocyte Globulin (Rabbit) (Thymoglobulin) (79 trials)
apalutamide (erleada) (11 trials)
aprepitant (Emend) (16 trials)
armodafinil (nuvigil) (9 trials)
arsenic trioxide (trisenox) (50 trials)
asparaginase (elspar) (47 trials)
atezolizumab (Tecentriq) (64 trials)
atrasentan hydrochloride (4 trials)
autologous cd34+ cells (3 trials)
autologous hematopoietic stem cells (349 trials)
autologous microbiome (1 trial)
autologous mononuclear stem cell (10 trials)
autologous umbilical cord blood (29 trials)
avelumab (bavencio) (28 trials)
azacitidine (vidaza) (84 trials)
bacille calmette-guerin (8 trials)
beclomethasone (vanceril) (3 trials)
bendamustine (treanda) (30 trials)
bevacizumab (avastin) (304 trials)
bicalutamide (casodex) (49 trials)
bleomycin (blenoxane) (39 trials)
blinatumomab (blincyto) (12 trials)
bone marrow derived mononuclear cells (1 trial)
bortezomib (velcade) (199 trials)
brentuximab vedotin (adcetris) (26 trials)
budesonide (rhinocort) (4 trials)
buserelin (receptal) (7 trials)
busulfan (Myleran) (135 trials)
cabozantinib (cometriq) (46 trials)
calaspargase pegol (Asparlas) (4 trials)
capecitabine (xeloda) (168 trials)
captopril (capoten) (3 trials)
carboplatin (paraplatin) (529 trials)
carboxyamidotriazole (7 trials)
carfilzomib (kyprolis) (27 trials)
carmustine (bicnu) (100 trials)
caspofungin (cancidas) (6 trials)
cefepime (maxipeme) (2 trials)
celecoxib (celebrex) (92 trials)
cephalexin (keflex) (2 trials)
cetuximab (erbitux) (125 trials)
chlorambucil (Leukeran) (2 trials)
chlorhexidine (hibitane) (1 trial)
ciprofloxacin (cipro) (3 trials)
cisplatin (platinol) (552 trials)
cladribine (leustatin) (22 trials)
clarithromycin (biaxin) (6 trials)
clofarabine (clolar) (32 trials)
conjugated equine estrogens (Premarin) (4 trials)
corticorelin ovine triflutate (acthrel) (1 trial)
crizotinib (xalkori) (14 trials)
cyclophosphamide (cytoxan) (863 trials)
cyclosporine (sandimmune) (160 trials)
cyproheptadine (periactin) (2 trials)
cytarabine (cytosar-u) (362 trials)
dabrafenib (tafinlar) (20 trials)
dacarbazine (dtic-dome) (28 trials)
daclizumab (Zenapax) (4 trials)
dactinomycin (cosmegen) (24 trials)
darbepoetin alfa (aranesp) (6 trials)
darolutamide (Nubeqa) (5 trials)
dasatinib (sprycel) (67 trials)
daunorubicin (cerubidine) (113 trials)
decitabine (dacogen) (74 trials)
degarelix acetate (firmagon) (10 trials)
dexrazoxane (zinecard) (24 trials)
dinutuximab (unituxin) (13 trials)
diphenhydramine (benadryl) (8 trials)
docetaxel (taxotere) (304 trials)
dolasetron (anzemet) (3 trials)
donepezil (aricept) (5 trials)
doxorubicin (Doxil) (513 trials)
doxycycline (vibramycin) (5 trials)
dronabinol (marinol) (1 trial)
durvalumab (imfinzi) (54 trials)
dutasteride (avodart) (1 trial)
eflornithine (ornidyl) (17 trials)
emtricitabine (emtriva) (1 trial)
encorafenib (braftovi) (11 trials)
enzalutamide (xtandi) (28 trials)
epirubicin (ellence) (25 trials)
eribulin (halaven) (19 trials)
erlotinib (tarceva) (157 trials)
erwinia asparaginase (Erwinaze) (6 trials)
escitalopram (lexapro) (1 trial)
estramustine (emcyt) (23 trials)
etanercept (enbrel) (8 trials)
etoposide (vepesid) (480 trials)
everolimus (zortress) (70 trials)
Filgrastim (neupogen) (83 trials)
fish oil (Omegavan) (5 trials)
floxuridine (fudr) (24 trials)
fluconazole (diflucan) (5 trials)
flucytosine (ancobon) (5 trials)
fludarabine (fludara) (361 trials)
fludeoxyglucose f-18 (92 trials)
flutamide (eulexin) (32 trials)
fulvestrant (faslodex) (25 trials)
Ga 68 PSMA-11 (Illuccix) (10 trials)
ganciclovir (cytovene) (10 trials)
gastrin 17 vaccine (Gastrimmune) (1 trial)
gefitinib (iressa) (59 trials)
gemcitabine (gemzar) (402 trials)
gemtuzumab ozogamicin (mylotarg) (23 trials)
glutathione (Furadantin) (1 trial)
gonadorelin (factrel) (2 trials)
goserelin (zoladex) (63 trials)
gp-100 peptide vaccine (53 trials)
granisetron (kytril) (8 trials)
haloperidol (haldol) (4 trials)
heparin (liquaemin) (2 trials)
hexyl 5-aminolevulinate (Cysview) (1 trial)
high-selenium yeast (2 trials)
histrelin (supprelin) (3 trials)
human fibrin (Tisseel) (3 trials)
humanised anti-cd22 antibody (8 trials)
human papillomavirus quadrivalent (types 6, 11, 16 and 18) vaccine, recombinant (Gardasil) (8 trials)
hyaluronidase (human recombinant) (Hylenex) (14 trials)
hydrocodone (hycodan) (1 trial)
hydrocortisone (solu-cortef) (7 trials)
hydroxychloroquine (plaquenil) (29 trials)
hydroxyurea (hydrea) (22 trials)
hypericum perforatum (5 trials)
ibandronate (boniva) (2 trials)
ibritumomab tiuxetan (Zevalin) (32 trials)
ibrutinib (imbruvica) (57 trials)
icosapent ethyl (vascepa) (14 trials)
idarubicin (idamycin) (46 trials)
ifosfamide (ifex) (125 trials)
il13r alpha peptide (2 trials)
imatinib (gleevec) (101 trials)
imiquimod (aldara) (16 trials)
immune globulin (human) (Gamastan) (3 trials)
inactivated influenza vaccine (7 trials)
indocyanine green (ic-green) (16 trials)
infliximab (remicade) (5 trials)
inotuzumab ozogamicin (besponsa) (6 trials)
interferon alpha-2b (Intron-A) (124 trials)
interferon gamma-1b (actimmune) (15 trials)
iobenguane sulfate i-131 (11 trials)
ipilimumab (yervoy) (119 trials)
iron dextran (INFeD) (1 trial)
isosulfan blue (lymphazurin) (9 trials)
isotretinoin (Accutane) (39 trials)
itraconazole (sporanox) (4 trials)
ixabepilone (ixempra) (55 trials)
ixazomib (ninlaro) (30 trials)
ketoconazole (nizoral) (20 trials)
lactobacillus brevis (1 trial)
lactobacillus plantarum (3 trials)
lapatinib (tykerb) (50 trials)
lenalidomide (revlimid) (150 trials)
letermovir (prevymis) (2 trials)
levamisole (ergamisol) (3 trials)
levocarnitine (carnitor) (4 trials)
levofloxacin (levaquin) (2 trials)
lidocaine (xylocaine) (9 trials)
loperamide (imodium) (2 trials)
lysergic acid diethylamide (2 trials)
mechlorethamine (mustargen) (5 trials)
medroxyprogesterone (provera) (7 trials)
megestrol (megace) (17 trials)
melphalan (alkeran) (196 trials)
memantine (namenda) (8 trials)
mercaptopurine (purinethol) (69 trials)
methadone (methadose) (3 trials)
methylene blue (proveblue) (14 trials)
methylprednisolone (medrol) (60 trials)
micafungin (mycamine) (2 trials)
midostaurin (rydapt) (5 trials)
mifepristone (mifeprex) (3 trials)
mitomycin (mutamycin) (33 trials)
mitotane (lysodren) (4 trials)
mitoxantrone (novantrone) (71 trials)
modafinil (provigil) (5 trials)
moxifloxacin (avelox) (1 trial)
mycophenolate (CellCept) (146 trials)
myeloma immunoglobulin idiotype vaccine-klh (1 trial)
n-(4-hydroxyphenyl)all-trans retinamide (31 trials)
naloxegol (movantik) (1 trial)
naproxen (naprosyn) (3 trials)
nelarabine (arranon) (12 trials)
netupitant (Akynzeo) (2 trials)
nilutamide (nilandron) (8 trials)
nivolumab (opdivo) (193 trials)
nystatin (mycostatin) (2 trials)
obinutuzumab (gazyva) (21 trials)
octreotide (sandostatin) (24 trials)
olanzapine (zyprexa) (6 trials)
olaparib (lynparza) (58 trials)
omacetaxine (synribo) (7 trials)
omeprazole (prilosec) (7 trials)
ondansetron (zofran) (12 trials)
osimertinib (tagrisso) (15 trials)
oxandrolone (oxandrin) (1 trial)
oxybutynin (ditropan) (2 trials)
paclitaxel (taxol) (628 trials)
palbociclib (ibrance) (24 trials)
palifermin (Kepivance) (11 trials)
palivizumab (Synagis) (1 trial)
palonosetron (aloxi) (8 trials)
pamidronate (aredia) (5 trials)
panitumumab (vectibix) (25 trials)
pazopanib (votrient) (45 trials)
pegaspargase (oncaspar) (51 trials)
pembrolizumab (keytruda) (201 trials)
pemetrexed (alimta) (101 trials)
pentosan polysulfate sodium (elmiron) (1 trial)
peripheral blood lymphocytes (32 trials)
pertuzumab (perjeta) (16 trials)
pilocarpine (ocusert) (3 trials)
plerixafor (mozobil) (12 trials)
polyvalent antigen-klh conjugate vaccine (2 trials)
ponatinib (iclusig) (5 trials)
porfimer (photofrin) (8 trials)
prasterone (intrarosa) (2 trials)
prednisolone (hydeltra) (13 trials)
prednisone (meticorten) (271 trials)
prochlorperazine (compazine) (3 trials)
raloxifene (evista) (5 trials)
ramucirumab (cyramza) (16 trials)
relatlimab (Opdualag) (3 trials)
ribavirin (virazole) (4 trials)
rilimogene gamvacirepvec (8 trials)
risedronate (actonel) (3 trials)
rituximab (rituxan) (310 trials)
romiplostim (nplate) (28 trials)
ropivacaine (naropin) (1 trial)
rosuvastatin (crestor) (3 trials)
rucaparib (rubraca) (4 trials)
ruxolitinib (jakafi) (19 trials)
samarium-153 lexidronam (quadramet) (7 trials)
sargramostim (leukine) (676 trials)
secretin human (chirhostim) (1 trial)
selenomethionine se-75 (5 trials)
selumetinib (Koselugo) (44 trials)
shark cartilage extract ae-941 (2 trials)
sirolimus (rapamune) (88 trials)
sitagliptin (januvia) (36 trials)
sodium thiosulfate (13 trials)
sorafenib (nexavar) (138 trials)
styrene maleic acid neocarzinostatin (1 trial)
sulfamethoxazole (gantanol) (5 trials)
sulfasalazine (azulfidine) (1 trial)
sulindac (clinoril) (20 trials)
sunitinib (sutent) (70 trials)
tacrolimus (prograf) (126 trials)
temozolomide (temodar) (212 trials)
temsirolimus (torisel) (83 trials)
tenofovir alafenamide (genvoya) (1 trial)
testosterone (delatestryl) (9 trials)
thalidomide (Thalomid) (92 trials)
thiopental (pentothal) (1 trial)
tinidazole (tindamax) (1 trial)
tioguanine (Lanvis) (40 trials)
tocilizumab (actemra) (7 trials)
topotecan (hycamtin) (138 trials)
tositumomab (Bexxar) (9 trials)
trabectedin (yondelis) (14 trials)
trametinib (mekinist) (44 trials)
trastuzumab emtansine (kadcyla) (14 trials)
tretinoin (Retin-A) (25 trials)
triptorelin (Trelstar) (14 trials)
tumor necrosis factor (3 trials)
valaciclovir (Valtrex) (1 trial)
valeriana officinalis (1 trial)
valganciclovir (Valcyte) (7 trials)
venetoclax (venclexta) (58 trials)
venlafaxine (effexor) (3 trials)
vinblastine (velban) (50 trials)
vincristine (oncovin) (347 trials)
vinorelbine (navelbine) (60 trials)
vinyl alcohol polymer (1 trial)
vocimagene amiretrorepvec (1 trial)
voriconazole (vfend) (10 trials)
vorinostat (zolinza) (91 trials)
warfarin (coumadin) (3 trials)
ytttrium-90 microspheres (5 trials)
zanubrutinib (Brukinsa) (4 trials)
zidovudine (retrovir) (11 trials)
12 peptide melanoma vaccine (1 trial)
23-valent pneumococcal polysaccharide vaccine (pneumovax-23) (5 trials)
2-fluoropropionyl-labeled pegylated dimeric rgd peptide (1 trial)
3,4-dihydroxyphenylalaninechrome tautomerase (1 trial)
4-demethyl-4-cholesteryloxycarbonylpenclomedine (3 trials)
7-hydroxystaurosporine (22 trials)
90y-dota-tyr3-octreotide (1 trial)
abemaciclib (verzenio) (15 trials)
acalabrutinib (calquence) (14 trials)
acetic acid (vosol) (10 trials)
acetylcysteine (mucomyst) (3 trials)
aflibercept (zaltrap) (27 trials)
alectinib (alecensa) (1 trial)
alemtuzumab (campath) (33 trials)
allogeneic adipose derived mesenchymal stem cell (1 trial)
allogeneic b7.1/hla-a1 transfected tumor cell vaccine (1 trial)
allogeneic cytomegalovirus-specific cytotoxic t lymphocytes (1 trial)
allogeneic epstein-barr virus specific cytotoxic t-lymphocytes (3 trials)
allogeneic gm-csf-secreting breast cancer vaccine (3 trials)
allogeneic lymphocytes (59 trials)
allogeneic natural killer cells (13 trials)
allogeneic tumor cell vaccine (2 trials)
allogenic gm-csf plasmid-transfected pancreatic tumor cell vaccine (1 trial)
allopurinol (zyloprim) (6 trials)
alpha (1,3) galactosyltransferase expressing allogeneic tumor cells (1 trial)
alpha fetoprotein adenoviral vector vaccine (1 trial)
alpha-methyltryptophan (1 trial)
alprostadil (prostin) (1 trial)
alteplase (Activase) (1 trial)
alvac-cea-b7.1 vaccine (3 trials)
alvac mart-1 vaccine (2 trials)
alvac ny eso-1 vaccine (3 trials)
amino acids (Freamine) (5 trials)
aminoglutethimide (cytadren) (1 trial)
aminolevulinic acid (levulan) (15 trials)
amivantamab-vmjw (Rybrevant) (1 trial)
amphetamine (Adderall) (1 trial)
anetumab ravtansine (5 trials)
anti-egfrviii car transduced pbl (1 trial)
antigen pulsed dendritic cells (2 trials)
anti-gp 100:154 tcell receptor peripheral blood lymphocyte (1 trial)
anti-mage-a3-dp4 tcr (1 trial)
anti-mage-a3 hlaa* 01-restricted tcr (1 trial)
anti-mart-1 f5 tcr pbl (1 trial)
anti-ny eso-1 mtcr pbl (1 trial)
anti-ny eso-1 t cell receptor cd62l+ cells (1 trial)
anti-ny eso-1 t-cell receptor pbl (1 trial)
anti-p53 t-cell receptor-transduced peripheral blood lymphocytes (2 trials)
anti-vegfr2 car cd8 t cells (1 trial)
asciminib (Scemblix) (1 trial)
atorvastatin (lipitor) (10 trials)
attenuated live listeria encoding hpv 16 e7 vaccine (1 trial)
auranofin (ridaura) (4 trials)
autologous anti-cd19car-4-1bb-cd3zeta-egfrt-expressing t lymphocytes (2 trials)
autologous anti-gp 100:154-162 t-cell receptor gene-engineered peripheral blood lymphocytes (1 trial)
autologous anti-gp 100:154-162 t-cell receptor gene-engineered tumor infiltrating lymphocytes (1 trial)
autologous anti-mart-1 f5 t-cell receptor (1 trial)
autologous anti-mart-1 f5 t-cell receptor gene-engineered tumor infiltrating lymphocytes (3 trials)
autologous cd19car-cd28-cd3zeta-egfrt-expressing tn/mem-enriched t-lymphocytes (2 trials)
autologous cd19/cd22 chimeric antigen receptor t-cells (9 trials)
autologous dendritic cells (25 trials)
autologous dendritic cells loaded with autologous tumor lysate (2 trials)
autologous epstein-barr virus-specific cytotoxic t lymphocytes (1 trial)
autologous expanded mesenchymal stem cells oti-010 (1 trial)
autologous immunoglobulin idiotype-klh conjugate vaccine (2 trials)
autologous lymphocytes (35 trials)
autologous mesenchymal stem cells (3 trials)
autologous natural killer cells (2 trials)
autologous platelets (1 trial)
autologous regulatory t cells (3 trials)
autologous tumor cell vaccine (5 trials)
autologous tumor infiltrating lymphocytes (1 trial)
autologous wt1-tcrc4 gene-transduced cd8-positive tcm/tn lymphocytes (2 trials)
avapritinib (Ayvakit) (1 trial)
axicabtagene ciloleucel (Yescarta) (3 trials)
azithromycin (zithromax) (1 trial)
baricitinib (olumiant) (2 trials)
basiliximab (Simulect) (5 trials)
bazedoxifene (Duavee) (2 trials)
bcr-abl peptide vaccine (2 trials)
belantamab mafodotin (TECVAYLI) (2 trials)
belinostat (beleodaq) (25 trials)
beractant (survanta) (6 trials)
bexarotene (targretin) (6 trials)
bifidobacterium animalis (1 trial)
binimetinib (mektovi) (21 trials)
bismuth subsalicylate (Pepto-Bismol) (1 trial)
bivalent oral polio vaccine (bopv), type 1 and type 3 (BOPV) (2 trials)
bnt162b2 (Comirnaty) (1 trial)
boronophenylalanine-fructose complex (1 trial)
bosutinib (bosulif) (2 trials)
bowman-birk inhibitor (3 trials)
brigatinib (alunbrig) (5 trials)
broccoli sprout extract (3 trials)
bystander-based autologous tumor cell vaccine (1 trial)
cabazitaxel (jevtana kit) (3 trials)
calcitriol (rocaltrol) (12 trials)
camellia sinensis extract (1 trial)
canakinumab (ilaris) (1 trial)
candida albicans allergen (Candin) (2 trials)
capivasertib (Truqap) (1 trial)
capmatinib (Tabrecta) (3 trials)
capromab pendetide (Prostascint) (1 trial)
carcinoembryonic antigen peptide 1 (2 trials)
carcinoembryonic antigen rna-pulsed dc cancer vaccine (2 trials)
cd105/yb-1/sox2/cdh3/mdm2-polyepitope plasmid dna vaccine (2 trials)
cd19car-cd3zeta-4-1bb-expressing allogeneic t-lymphocyte cells (1 trial)
cd45-depleted allogenic peripheral blood stem cell (1 trial)
cd8 enriched young til (1 trial)
cedazuridine (Inqovi) (10 trials)
cemiplimab (libtayo) (4 trials)
ceritinib (zykadia) (3 trials)
cholestyramine (questran) (2 trials)
cidofovir (vistide) (2 trials)
cinacalcet (sensipar) (1 trial)
cintredekin besudotox (3 trials)
clobetasol (dermovate) (2 trials)
clopidogrel (plavix) (3 trials)
cmv-specific t-cells (4 trials)
cobimetinib (cotellic) (7 trials)
copanlisib (aliqopa) (17 trials)
copper-64 labeled granzyme b (1 trial)
ctl019 transduced cells (1 trial)
cyanocobalamin (berocca) (2 trials)
d1/3-mage-3-his fusion protein (1 trial)
danazol (danocrine) (2 trials)
dc/rcc fusion vaccine (1 trial)
dec-205/ny-eso-1 fusion protein cdx-1401 (4 trials)
deferasirox (exjade) (2 trials)
defibrotide (defitelio) (1 trial)
dendritic cell-gp100-mart-1 antigen vaccine (1 trial)
dendritic cell tumor fusion vaccine (6 trials)
diclofenac (voltaren) (2 trials)
dipyridamole (persantine) (1 trial)
disaccharide tripeptide glycerol dipalmitoyl (1 trial)
dmf5 melanoma reactive til (1 trial)
dostarlimab (Jemperli) (1 trial)
doxercalciferol (hectorol) (2 trials)
drosophila-peptide pulsed melanoma-reactive autologous cd8+ pbl (1 trial)
duvelisib (copiktra) (5 trials)
e7 tcr transduced pbl cells (7 trials)
egfrbi-armed autologous t cells (1 trial)
elacestrant (Orserdu) (1 trial)
elotuzumab (empliciti) (3 trials)
eltrombopag (promacta) (3 trials)
emepepimut-s (Stimuvax) (1 trial)
enasidenib (idhifa) (8 trials)
enfortumab vedotin (Padcev) (3 trials)
entrectinib (Rozlytrek) (1 trial)
Epcoritamab (Epkinly) (1 trial)
ephb4-hsa fusion protein (9 trials)
epstein-barr virus specific white blood cells (1 trial)
erdafitinib (Balversa) (5 trials)
esomeprazole (nexium) (1 trial)
estradiol (progynon depot) (6 trials)
estrogens, esterified (menrium component estrogens, esterified) (1 trial)
etaracizumab (abegrin) (3 trials)
ethinyl estradiol (Estinyl) (2 trials)
ethiodized oil (ethiodol) (1 trial)
etirinotecan pegol (Onzeald) (2 trials)
ex vivo-expanded her2-specific t cells (3 trials)
f5 tcr transgenic cells (1 trial)
fenofibrate (fenoglide) (1 trial)
ferumoxytol (feraheme) (14 trials)
fesoterodine (toviaz) (1 trial)
flecainide (tambocor) (1 trial)
fluocinonide (lidex) (1 trial)
fluorodopa (fluorodopa F18) (4 trials)
fluoroestradiol (Cerianna) (6 trials)
fluorofuranylnorprogesterone (1 trial)
fluoromethylcholine (18f) (FCH) (2 trials)
fluoromisonidazole (10 trials)
fluticasone (cutivate) (1 trial)
fluvastatin (lescol) (1 trial)
fowlpox-prostate specific antigen vaccine (3 trials)
fowlpox virus vaccine (4 trials)
fucosylated regulatory t cells (1 trial)
futibatinib (Lytgobi) (1 trial)
gadobutrol (gadavist) (5 trials)
gadopenteate dimeglumine (magnevist) (9 trials)
galantamine (reminyl) (1 trial)
gallium-68-dotatate (netspot) (4 trials)
gallium nitrate (ganite) (2 trials)
genetically engineered lymphocyte therapy (2 trials)
genetically-modified neural stem cells expressing e.coli cytosine deaminase (1 trial)
glasdegib (Daurismo) (2 trials)
glembatumumab vedotin (3 trials)
glofitamab (Columvi) (2 trials)
gm-k562 cell vaccine (4 trials)
gm-neo and panc 6.03 pcdna-1 (1 trial)
gvax lung cancer vaccine (1 trial)
gvax pancreatic cancer vaccine (2 trials)
gvax prostate cancer vaccine (1 trial)
h1299 lysate vaccine (1 trial)
haploidentical mononuclear cells (1 trial)
hemopoietic stem cell (8 trials)
her2bi-armed activated t cells (4 trials)
her-2/neu peptide vaccine (7 trials)
herba scutellaria barbata (1 trial)
hla-a2 restricted glioma antigen-peptides (1 trial)
hodgkin's antigens-gm-csf-expressing cell vaccine (2 trials)
htert i540/r572y/d988y multipeptide vaccine (1 trial)
human papillomavirus 16 monovalent (3 trials)
idecabtagene vicleucel (Abecma) (1 trial)
idelalisib (zydelig) (5 trials)
idiotype-pulsed allogeneic dendritic cells (1 trial)
idiotype tumor cell vaccine (2 trials)
idoxuridine (herplex) (2 trials)
il-12 transduced til (1 trial)
iloprost (ventavis) (3 trials)
in111 monoclonal antibody mn-14 (5 trials)
incomplete freund's adjuvant (51 trials)
indomethacin (indocin) (4 trials)
infigratinib (Truseltiq) (5 trials)
interferon alfa-1b (Rebif) (2 trials)
interferon alpha-2a (roferon-a) (2 trials)
in vitro tumor reactive, chimeric t cell receptor gene-transduced pbl (1 trial)
irradiated donor lymphocyte (2 trials)
Isatuximab (Sarclisa) (2 trials)
isavuconazonium (cresemba) (1 trial)
ivosidenib (tibsovo) (5 trials)
k562 cell line transfected with hcd40l and hgm-csf (1 trial)
keyhole limpet hemocyanin (9 trials)
lamivudine (epivir) (2 trials)
lentivirus vector ccr5 shrna/trim5alpha/tar decoy-transduced autologous cd34-positive hematopoietic progenitor cells (1 trial)
lenvatinib (lenvima) (10 trials)
lepirudin (refludan) (1 trial)
liothyronine (cytomel) (3 trials)
liposomal hpv-16 e6/e7 multipeptide vaccine pds0101 (2 trials)
liposomal interleukin-2 (1 trial)
lisinopril (zestril) (5 trials)
lisocabtagene maraleucel (Breyanzi) (2 trials)
lithium (lithonate) (4 trials)
l-leucyl-l-leucine methyl ester (1 trial)
lmp-specific cytotoxic t-lymphocytes (2 trials)
loncastuximab (Zynlonta) (2 trials)
lorlatinib (lorbrena) (2 trials)
lorvotuzumab mertansine (1 trial)
lovastatin (mevacor) (2 trials)
lu177 monoclonal antibody j591 (1 trial)
lurbinectedin (Zepzelca) (3 trials)
luspatercept (Reblozyl) (1 trial)
lutetium dotatate lu-177 (Lutathera) (13 trials)
lymphocyte immune globulin, anti-thymocyte globulin (equine) (Atgam) (3 trials)
mannitol (Osmitrol) (4 trials)
maraviroc (selzentry) (1 trial)
mart-1, gp100, tyrosinase peptides (1 trial)
mart-1 peptide pulsed dendritic cells (33 trials)
mart-1 reactive cd8+ pbl (1 trial)
mcpyv tag-specific polyclonal autologous cd8-positive t cells (2 trials)
melanoma peptide-pulsed dendritic cells (1 trial)
melanoma reactive til (1 trial)
melitac 12.1 peptide vaccine (1 trial)
mesothelin car t cells (1 trial)
metformin (glucophage) (9 trials)
methoxy polyethylene glycol-epoetin beta (Mircera) (1 trial)
metronidazole (flagyl) (3 trials)
minocycline (minocin) (12 trials)
modified vaccinia ankara-5t4 vaccine (1 trial)
modified vaccinia virus ankara vaccine expressing p53 (4 trials)
mogamulizumab (poteligeo) (4 trials)
momelotinib (Ojjaara) (1 trial)
monoclonal antibody cal (1 trial)
monoclonal antibody cd19 (1 trial)
monoclonal antibody cd20 (1 trial)
monoclonal antibody gd2 anti-idiotype vaccine (1 trial)
monosialotetrahexosyl ganglioside (1 trial)
montelukast (singulair) (2 trials)
mosunetuzumab (Lunsumio) (4 trials)
motexafin gadolinium (24 trials)
mrna-1273 (Spikevax) (2 trials)
muc-1 peptide vaccine (4 trials)
multi-epitope folate receptor alpha peptide vaccine (2 trials)
multi-epitope melanoma peptide vaccine (7 trials)
multi-peptide cmv-modified vaccinia ankara vaccine (7 trials)
muromonab cd3 (Orthoclone OKT3) (8 trials)
myeloma immunoglobulin idiotype vaccine (1 trial)
naxitamab (Danyelza) (10 trials)
nelfinavir (viracept) (10 trials)
neoantigen-based melanoma vaccine (1 trial)
neoantigen reactive t cells (2 trials)
neratinib maleate (nerlynx) (2 trials)
nevirapine (viramune) (1 trial)
niclosamide (nicloside) (3 trials)
nilotinib (tasigna) (15 trials)
nirogacestat (Ogsiveo) (3 trials)
ny-eso-1 reactive tcr retroviral vector transduced autologous pbl (3 trials)
obeticholic acid (ocaliva) (2 trials)
ofatumumab (arzerra) (6 trials)
Ofranergene obadenovec (1 trial)
olaratumab (lartruvo) (1 trial)
oligofructose-enriched inulin (1 trial)
oncolytic measles virus encoding thyroidal sodium iodide symporter (7 trials)
oprelvekin (Neumega) (2 trials)
p53 peptide vaccine (3 trials)
palmitoylethanolamide (1 trial)
panobinostat (farydak) (10 trials)
paricalcitol (zemplar) (5 trials)
pasireotide (signifor) (1 trial)
peginterferon beta-1a (Plegridy) (3 trials)
peg-pei-cholesterol lipopolymer-encased il-12 dna plasmid vector gen-1 (1 trial)
pemigatinib (Pemazyre) (2 trials)
penicillamine (cuprimine) (1 trial)
pentamidine (pentam) (2 trials)
pentetate calcium trisodium (169yb) (1 trial)
pentostatin (nipent) (25 trials)
pentoxifylline (trental) (3 trials)
perfluorobutane (Sonazoid) (1 trial)
perfosfamide (Pergamid) (1 trial)
peripheral blood progenitor cells carrying mdr1 (1 trial)
personalized synthetic long peptide vaccine (1 trial)
pexastimogene devacirepvec (1 trial)
pexidartinib (Turallo) (2 trials)
pg13-mage-a3 tcr9w11 transduced autologous peripheral blood lymphocytes (1 trial)
phenelzine (nardil) (2 trials)
phenethyl isothiocyanate (2 trials)
phentolamine mesylate (regitine) (1 trial)
phenylacetic acid (ucephan) (1 trial)
phenylephrine (Prefrin) (1 trial)
piflufolastat (PYLARIFY) (13 trials)
pioglitazone (actos) (5 trials)
piperacillin (pipracil) (1 trial)
pirfenidone (esbriet) (3 trials)
plicamycin (mithracin) (3 trials)
pneumococcal 13-valent conjugate vaccine (prevnar 13) (6 trials)
polatuzumab vedotin (Polivy) (7 trials)
polysaccharide-k (KRESTIN) (1 trial)
pomalidomide (pomalyst) (31 trials)
potassium iodide (thyro-block) (1 trial)
pralatrexate (folotyn) (7 trials)
pravastatin (pravachol) (4 trials)
prilocaine (citanest) (1 trial)
propofol (diprivan) (2 trials)
propranolol (inderal) (4 trials)
prostatic acid phosphatase-sargramostim fusion protein (1 trial)
psa:154-163 peptide vaccine (1 trial)
psa prostate cancer vaccine (3 trials)
psa rna-pulsed dendritic cell vaccine (1 trial)
quizartinib (VANFLYTA) (7 trials)
radiolabeled albumin technetium Tc-99m albumin colloid kit (Microlite) (2 trials)
ranitidine (zantac) (2 trials)
rasburicase (Elitek) (2 trials)
ras peptide cancer vaccine (7 trials)
recombinant adenoviral human p53 gene (17 trials)
recombinant fowlpox-cea(6d)/tricom vaccine (8 trials)
recombinant fowlpox-tyrosinase vaccine (1 trial)
regorafenib (stivarga) (14 trials)
retifanlimab (Zynyz) (3 trials)
ribociclib (kisqali) (9 trials)
rifaximin (xifaxan) (2 trials)
rimabotulinumtoxinB (Myobloc) (2 trials)
romidepsin (istodax) (38 trials)
(s)-4-(3-fluoropropyl)-l-glutamic acid (2 trials)
sacituzumab govitecan (Trodelvy) (6 trials)
s-adenosyl methionine (1 trial)
sargramostim plasmid dna hepatocellular carcinoma vaccine adjuvant (1 trial)
selinexor (Xpovio) (19 trials)
Selpercatinib (Retevmo) (3 trials)
semaglutide (Ozempic) (1 trial)
seneca valley virus (2 trials)
sevoflurane (ultane) (2 trials)
sildenafil (viagra) (4 trials)
siltuximab (sylvant) (4 trials)
simvastatin (zocor) (7 trials)
sipuleucel-t (Provenge) (2 trials)
sodium aluminosilicate (1 trial)
sodium fluoride (18F) (10 trials)
sodium phenylbutyrate (buphenyl) (9 trials)
sotorasib (LUMAKRAS) (3 trials)
spironolactone (aldactone) (1 trial)
survivin peptide vaccine (1 trial)
svn53-67/m57-klh peptide vaccine (2 trials)
synthetic tumor-associated peptide vaccine therapy (1 trial)
T4-bacteriophage endonuclease V (1 trial)
tafasitamab (Monjuvi) (4 trials)
tagraxofusp-erzs (elzonris) (2 trials)
talazoparib (talzenna) (18 trials)
talimogene laherparepvec (Imlygic) (6 trials)
tazarotene (tazorac) (2 trials)
tazemetostat (Tazverik) (9 trials)
tc99m-tilmanocept (Lymphoseek) (3 trials)
t cell depleted hematopoietic stem cells (1 trial)
technetium tc-99m sestamibi (Cardiolite) (5 trials)
technetium tc-99m sulfur colloid kit (Tesuloid) (12 trials)
telomerase: 540-548 peptide vaccine (3 trials)
telotristat ethyl (xermelo) (1 trial)
tepotinib (Tepmetko) (1 trial)
Tetanus and diphtheria toxoids adsorbed (Decavac) (3 trials)
tetanus peptide melanoma vaccine (2 trials)
tetracycline (tetrex) (2 trials)
tetradecanoylphorbol acetate (2 trials)
tetra-o-methyl nordihydroguaiaretic acid (1 trial)
tgfa-pe38 immunotoxin (1 trial)
tgfbdnrii-transduced autologous tumor infiltrating lymphocytes (1 trial)
theophylline (synophylate) (1 trial)
thyrotropin (Thyropar) (1 trial)
tinzaparin (Innohep) (1 trial)
tipiracil (lonsurf) (11 trials)
tisagenlecleucel (Kymriah) (2 trials)
tivozanib (Fotivda) (4 trials)
tremelimumab (Imjudo) (19 trials)
triamcinolone (kenalog) (1 trial)
trifluridine (viroptic) (10 trials)
trimetrexate (neutrexin) (4 trials)
trisalicylate choline (3 trials)
troglitazone (Rezulin) (1 trial)
tumor associated antigen specific cytotoxic t lymphocytes (2 trials)
tumor-draining lymph node lymphocyte (1 trial)
tumor lysate/klh pulsed dendritic cells (1 trial)
tumor-pulsed dendritic cells (6 trials)
tumor purged/cd25 depleted lymphocytes (1 trial)
tumour infiltrating lymphocytes (17 trials)
tyrosinase/gp100/mart-1 peptides (1 trial)
tyrosinase peptide (21 trials)
tyrosinase-related protein-1 (1 trial)
ublituximab (Briumvi) (2 trials)
umbralisib (Ukoniq) (4 trials)
urokinase-derived peptide a6 (1 trial)
ursodeoxycholic acid (3 trials)
vaccinia-b7.1 vaccine (3 trials)
vaccinia-cea(6d)-tricom vaccine (10 trials)
vaccinia-cea vaccine (1 trial)
vaccinia-gm-csf vaccine (1 trial)
vaccinia prostate-specific antigen vaccine (4 trials)
vaccinia-tyrosinase vaccine (2 trials)
valemetostat (Ezharmia) (2 trials)
valrubicin (valstar) (1 trial)
vancomycin (Vancocin) (5 trials)
vandetanib (caprelsa) (17 trials)
vedolizumab (entyvio) (2 trials)
vemurafenib (zelboraf) (7 trials)
verteporfin (visudyne) (1 trial)
vismodegib (erivedge) (22 trials)
von hippel-lindau peptide vaccine (1 trial)
white button mushroom extract (4 trials)
wild-type reovirus (10 trials)
wt1 126-134 peptide (2 trials)
wt1 peptide-pulsed dendritic cells (1 trial)
wt1-sensitized allogeneic t-lymphocytes (1 trial)
y90 anti-cd45 monoclonal antibody bc8 (5 trials)
y90 dota anti-cea monoclonal antibody m5a (5 trials)
y90 humanized anti-tac (2 trials)
y90 monoclonal antibody mn-14 (5 trials)
111in chx-a dtpa trastuzumab (1 trial)
124i-iodo-azomycin galacto-pyranoside (1 trial)
131i-metaiodobenzylguanidine (1 trial)
18f 5-fluoro-2'-deoxycytidine (1 trial)
212-lead pentixather (1 trial)
2g-1 tcr retroviral vector-transduced lyn (1 trial)
4-hydroxy-2,2,6,6-tetramethyl-1-hydroxypiperidine (1 trial)
5-aza-4'-thio-2'- deoxycytidine (1 trial)
70-kd heat-shock protein (1 trial)
9 peptides from her-2/neu, cea, & cta (1 trial)
ada-transduced cd34+ cells (1 trial)
adenoviral-mediated interferon-beta (1 trial)
adgmcaix-transduced autologous dendritic cells (1 trial)
ad-sig-hmuc-1/ecdcd40l vaccine (1 trial)
alitretinoin (panretin) (1 trial)
allogeneic cd123car-cd28-cd3zeta-egfrt-expressing t-lymphocytes (1 trial)
allogeneic dendritic cells (1 trial)
allogeneic k562 tumor cells (2 trials)
altretamine (hexalen) (1 trial)
anti-cd19 and anti-cd20 bicistronic car t- cells (1 trial)
anti-cd19-car cmv-specific t-lymphocytes (2 trials)
anti-cd20 b9e9 scfv-streptavidin fusion protein (1 trial)
anti-hla-a2/ny-eso-1 tcr-transduced autologous t lymphocytes (1 trial)
anti-slamf7 car t cells (1 trial)
autologous ad her2 dendritic cells (1 trial)
autologous anti-cd19car-4-1bb-cd3zeta-egfrt-expressing cd4+/cd8+ central memory t-lymphocytes jcar014 (1 trial)
autologous anti-psca-car-4-1bb/tcrzeta-cd19t-expressing t-lymphocytes (2 trials)
autologous bulk til 1383i tcr transduced t cells (1 trial)
autologous cd123car-cd28-cd3zeta-egfrt-expressing t lymphocytes (1 trial)
autologous cd19car-cd28-cd3zeta-egfrt-expressing tcm-enriched t cells (2 trials)
autologous dendritic cell adenovirus ccl21 vaccine (2 trials)
autologous epstein-barr virus-transformed b-lymphoblastoid cell vaccine (1 trial)
autologous monocytes (1 trial)
autologous muc1-activated t-cells (1 trial)
autologous ny-eso-1-specific cd8-positive t lymphocytes (2 trials)
autologous til 1383i tcr gene modified t cells (1 trial)
azurin-derived cell-penetrating peptide p28 (1 trial)
barf1-specific cytotoxic t-lymphocytes (1 trial)
betamethasone (celestone) (1 trial)
bis-choline tetrathiomolybdate (1 trial)
b-lymphocyte stimulator (1 trial)
btsc mrna-loaded dcs (1 trial)
buthionine sulfoximine (3 trials)
c46/ccr5/p140k lentiviral vector-transduced autologous hspcs (1 trial)
canarypox-hil-12 melanoma vaccine (1 trial)
candida urate oxidase (1 trial)
cannabidiol (Epidiolex) (1 trial)
carboxylesterase-expressing allogeneic neural stem cells (2 trials)
carcinoembryonic antigen-expressing measles virus (2 trials)
cd19car-cd28-cd3zeta-egfrt-expressing tcm-enriched t-lymphocytes (2 trials)
cea-loaded dendritic cells (1 trial)
certolizumab pegol (cimzia) (1 trial)
choline c11 (choline c-11) (1 trial)
clivatuzumab tetraxetan (1 trial)
clostridium butyricum (3 trials)
cmv pp65 peptide-loaded alpha-type-1 polarized dendritic cell vaccine (1 trial)
colloidal gold-bound tumor necrosis factor (2 trials)
conjugated linoleic acid (1 trial)
copper cu-64-dota-alendronate (1 trial)
copper cu 64-dota-pembrolizumab (1 trial)
cpg-stat3 sirna cas3/ss3 (1 trial)
cytokine induced killer cells (1 trial)
cytomegalovirus ie-1-specific cytotoxic t lymphocytes (1 trial)
cytomegalovirus pp65-specific cytotoxic t lymphocytes (1 trial)
dacomitinib (vizimpro) (1 trial)
dapagliflozin (farxiga) (1 trial)
dc/aml fusion vaccine (1 trial)
deglycosylated ricin a chain-conjugated anti-cd19/anti-cd22 immunotoxins (1 trial)
dehydroepiandrosterone (2 trials)
dendritic vaccine pulsed with glioma peptides (1 trial)
dextromethorphan (delsym) (2 trials)
dimethyl fumarate (tecfidera) (1 trial)
dimethyl sulfoxide (rimso) (1 trial)
disulfiram (antabuse) (1 trial)
dnr.npc-specific t cells (1 trial)
donor regulatory t lymphocytes (1 trial)
ebna1-specific cytotoxic t-lymphocytes (1 trial)
e. coli cd-expressing genetically modified neural stem cells (1 trial)
egfrviii car t cells (1 trial)
endostatin (endostar) (2 trials)
ex vivo-activated autologous lymph node lymphocytes (1 trial)
fingolimod (gilenya) (2 trials)
Flotufolastat (Posluma) (2 trials)
flu matrix peptide p58-66 (1 trial)
fowlpox-sargramostim (3 trials)
fructo-oligosaccharide (1 trial)
gene-modified tumor cell vaccine therapy (1 trial)
genetically engineered hematopoietic stem cells (1 trial)
genetically engineered ny-eso-1-specific t lymphocytes (1 trial)
glucarpidase (voraxaze) (2 trials)
gp100-fowlpox vaccine (1 trial)
hepatitis a vaccine, inactivated (vaqta) (2 trials)
hepatitis b vaccine (recombinant) (Recombivax) (3 trials)
hpv16 rg1 vlp vaccine (1 trial)
hsp110-gp100 chaperone complex vaccine (1 trial)
human fecal microbiota (Reybota) (1 trial)
human papillomavirus 16 e7 peptide (2 trials)
human prostate-specific membrane antigen plasmid dna vaccine (1 trial)
hyperpolarized carbon 13 alpha-ketoglutarate (1 trial)
il-12 & anti-ny eso1 tcr pbl (1 trial)
il13ralpha2-specific hinge-optimized 41bb-co-stimulatory car truncated cd19-expressing autologous t-lymphocytes (2 trials)
il13ralpha2-specific, hinge-optimized, 41bb-costimulatory car/truncated cd19-expressing autologous t lymphocytes (1 trial)
il13ralpha2-specific hinge-optimized 4-1bb-co-stimulatory car/truncated cd19-expressing autologous tn/mem cells (Biological) (1 trial)
in111 anti-cd45 monoclonal antibody bc8 (2 trials)
in 111-dota-basiliximab (1 trial)
in111 monoclonal antibody hu3s193 (1 trial)
interferon beta-1b (betaseron) (1 trial)
iodine i 131 monoclonal antibody cc49-deltach2 (1 trial)
iohexol (Omnipaque) (2 trials)
klh conjugates of gd2l, gd3l, globo h, fucosyl gm1 (1 trial)
klh-pulsed tumor cell vaccine (1 trial)
kras peptide vaccine (1 trial)
Laromustine (onrigin) (2 trials)
levobupivacaine (chirocaine) (1 trial)
levorphanol tartrate (levo-dromoran) (1 trial)
linaclotide (linzess) (2 trials)
loratadine (claritin) (1 trial)
lutetium (177Lu) vipivotide tetraxetan (Pluvicto) (1 trial)
lv-nyeso tcr /sr39tk pbsc (1 trial)
lvsh5/c46 (cal-1) transduced cd34+ hematopoietic stem cells (1 trial)
mage-12 peptide vaccine (1 trial)
mannose binding lectin (2 trials)
margetuximab (Margenza) (1 trial)
masoprocol (actinex) (1 trial)
methyl aminolevulinate (metvixia) (1 trial)
methyl bacteriopurpurinimide (1 trial)
mibefradil (Posicor) (1 trial)
mirvetuximab soravtansine (Elahere) (1 trial)
monoclonal antibody 3a1 (1 trial)
monoclonal antibody e2.3 (1 trial)
monoclonal antibody f19 (1 trial)
monoclonal antibody mono-dga-rfb4 (1 trial)
monoclonal antibody muj591 (1 trial)
mouse prostate-specific membrane antigen plasmid dna vaccine (1 trial)
mov-gamma chimeric receptor gene (1 trial)
moxetumomab pasudotox (Lumoxiti) (2 trials)
muc1-klh conjugate vaccine (1 trial)
muc1-klh vaccine/qs21 (3 trials)
muc-2-globo h-klh conjugate vaccine (2 trials)
multi-virus-specific cytotoxic t lymphocytes (1 trial)
mva-brachyury-tricom (2 trials)
mvf-her-2(628-647)-crl 1005 vaccine (1 trial)
myeloid progenitor cells (1 trial)
necitumumab (portrazza) (2 trials)
neoantigen dna vaccine (1 trial)
neural stem cells-expressing crad-s-pk7 (1 trial)
nitric oxide (inomax) (1 trial)
nortriptyline (aventyl) (1 trial)
n-propionylated polysialic acid (1 trial)
ny-eso-1(157-165) peptide-pulsed autologous dendritic cell vaccine (1 trial)
ny-eso-1, magea4, prame, survivin and ssx - specific t cells (1 trial)
ny-eso-1-specific t cells (1 trial)
omega-3 fatty acids (Omacor) (1 trial)
oncolytic measles virus encoding helicobacter pylori neutrophil-activating protein (1 trial)
oncolytic polio/rhinovirus recombinant (1 trial)
oncolytic virus cf33-expressing hnis/anti-pd-l1 antibody (1 trial)
opioid growth factor (1 trial)
ovarian cancer peptide vaccine (1 trial)
paliperidone (invega) (1 trial)
personalized neoantigen vaccine (3 trials)
(pg13-a(f/k-f-sgsg-t2a-b (opt) (2g-1 tcr) retroviral vector-transduced lymphocyte (1 trial)
plecanatide (trulance) (1 trial)
prame/ssx/mage-specific t cells (1 trial)
proanthocyanidin extract (1 trial)
pumvc3-igfbp2-her2-igf1r (1 trial)
Raltitrexed (Tomudex) (4 trials)
recombinant adenovirus-hifn-beta (1 trial)
recombinant fowlpox-b7.1 vaccine (1 trial)
recombinant vesicular stomatitis virus-expressing interferon-beta (1 trial)
rindopepimut (Rintega) (1 trial)
rna-loaded dendritic cell vaccine (1 trial)
rocuronium (zemuron) (2 trials)
ror1 car-specific autologous t-lymphocytes (1 trial)
se-methyl-seleno-l-cysteine (2 trials)
silicon phthalocyanine (3 trials)
sirna-transfected peripheral blood mononuclear cells apn401 (2 trials)
sodium aurothiomalate (1 trial)
sodium stibogluconate (Pentostam) (2 trials)
staphylococcus enterotoxin b (1 trial)
stem cells treated with the anti-b7 antibodies (1 trial)
synthetic breast cancer peptides (1 trial)
synthetic human papillomavirus 16 e6 peptide (1 trial)
talactoferrin alpha (2 trials)
tarp dendritic cell vaccine (1 trial)
tarp peptide vaccine (1 trial)
taurolidine (Defencath) (2 trials)
technetium tc-99m medronate kit (1 trial)
tetanus-cmv fusion peptide vaccine (2 trials)
tetrahydrocannabinol (1 trial)
tf(c)-klh conjugate vaccine (1 trial)
thomsen-friedenreich antigen (1 trial)
tofacitinib (xeljanz) (1 trial)
tolbutamide (orinase) (1 trial)
transferrin receptor-targeted liposomal p53 cdna (1 trial)
triphosphoric acid adenosine ester (1 trial)
tucotuzumab celmoleukin (1 trial)
tumor-derived lyphocytes (1 trial)
vaccine comprised of klh conjugates of gd2l, gd3l, globo h, fucosyl gm1, (1 trial)
vaccinia-muc1 vaccine (1 trial)
varicella zoster virus glycoprotein e antigen (Shingrix) (1 trial)
vesicular stomatitis virus-expressing interferon-beta and tyrosinase related protein 1 (1 trial)
y90 monoclonal antibody b3 (1 trial)
y90 monoclonal antibody hu3s193 (3 trials)
18f-fluoro-dihydroxyphenylalanine (1 trial)
acitretin (soriatane) (2 trials)
allogenic t cell-depleted hematopoietic stem cells (1 trial)
anti-thyroglobulin mtcr-transduced autologous peripheral blood lymphocytes (1 trial)
daclatasvir (daklinza) (1 trial)
daptomycin (cubicin) (1 trial)
dendritic cell activated lymphocyte (1 trial)
desflurane (suprane) (1 trial)
desipramine (pertofrane) (1 trial)
deuterated phenanthrene (1 trial)
dolutegravir (tivicay) (1 trial)
gadodiamide (Omniscan) (1 trial)
gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid (Primovist) (1 trial)
gadoteric acid (Dotarem) (1 trial)
gadoteridol (prohance) (1 trial)
gag:267-274 peptide vaccine (1 trial)
globo-h-gm2-lewis-y-muc1-32(aa)-stn(c)-tf(c)-tn(c)-klh conjugate vaccine (1 trial)
her-2-neu, cea peptides, gm-csf, montanide isa-51 vaccine (1 trial)
hla-a2 restricted synthetic tumor antigen (1 trial)
human choriogonadotropin alfa (hCG) (1 trial)
lactobacillus rhamnosus (2 trials)
lentivirus vector rhiv7-shi-tar-ccr5rz-transduced hematopoietic progenitor cells (2 trials)
misoprostol (cytotec) (1 trial)
multi-epitope folate receptor alpha-loaded dendritic cell vaccine (1 trial)
polygonum cuspidatum extract (1 trial)
raltegravir (isentress) (1 trial)
sialyl lewis-keyhole limpet hemocyanin conjugate vaccine (1 trial)
technetium tc 99 hydrazinonicotinamide-tricine-linked interleukin-2 (1 trial)
Abdominal Neoplasms (Phase 2)
Aberrant Crypt Foci (Phase 2)
Acquired Immunodeficiency Syndrome (Phase 3)
Acrodermatitis (Phase 2)
ACTH-Secreting Pituitary Adenoma (Phase 2)
Acute Disease (Phase 3)
Acute Lung Injury (Phase 1)
Adamantinoma (Phase 2)
Adenocarcinoma (Phase 4)
Adenocarcinoma, Bronchiolo-Alveolar (Phase 3)
Adenocarcinoma, Clear Cell (Phase 3)
Adenocarcinoma, Follicular (Phase 2)
Adenocarcinoma, Mucinous (Phase 3)
Adenocarcinoma of Lung (Phase 3)
Adenocarcinoma, Papillary (Phase 2)
Adenoma (Phase 3)
Adenoma, Acidophil (Phase 1)
Adenoma, Basophil (Phase 1)
Adenoma, Chromophobe (Phase 1)
Adenoma, Islet Cell (Phase 3)
Adenoma, Liver Cell (Phase 2)
Adenomatous Polyposis Coli (Phase 3)
Adenomatous Polyps (Phase 3)
Adenomyoepithelioma (Phase 2)
Adenosarcoma (Phase 2)
Adrenal Cortex Neoplasms (Phase 3)
Adrenal Gland Neoplasms (Phase 1)
Adrenocortical Carcinoma (Phase 3)
Aggression (Phase 2)
AIDS-Related Complex (Phase 3)
Albuminuria (Phase 2)
Ameloblastoma (Phase 2)
Amyloidosis (Phase 3)
Anemia (Phase 4)
Anemia, Aplastic (Phase 2)
Anemia, Diamond-Blackfan (Phase 2)
Anemia, Hemolytic (Phase 2)
Anemia, Hemolytic, Autoimmune (Phase 2)
Anemia, Refractory (Phase 3)
Anemia, Sickle Cell (Phase 2)
Angiomyolipoma (Phase 2)
Anorexia (Phase 3)
Anus Neoplasms (Phase 3)
Anxiety Disorders (Phase 2)
Arsenic Poisoning (Phase 3)
Arthralgia (Phase 3)
Ascites (Phase 3)
Aspergillosis (Phase 3)
Astrocytoma (Phase 3)
Atrophy (Phase 2)
Atypical Squamous Cells of the Cervix (Phase 2)
Autoimmune Diseases (Phase 2)
Bacterial Infections (Phase 3)
Barrett Esophagus (Phase 2)
Basal Cell Nevus Syndrome (Phase 2)
Beckwith-Wiedemann Syndrome (Phase 3)
Behavior, Addictive (Phase 3)
beta-Thalassemia (Phase 2)
Bile Duct Neoplasms (Phase 3)
Biliary Tract Neoplasms (Phase 3)
Birt-Hogg-Dube Syndrome (Phase 2)
Blast Crisis (Phase 2)
Blood Platelet Disorders (Phase 2)
Body Weight (Phase 3)
Body Weight Changes (Phase 3)
Bone Diseases (Phase 3)
Bone Diseases, Metabolic (Phase 2)
Bone Marrow Diseases (Phase 3)
Bone Neoplasms (Phase 3)
Brain Diseases (Phase 2)
Brain Edema (Phase 2)
Brain Neoplasms (Phase 4)
Brain Stem Neoplasms (Phase 2)
Breast Carcinoma In Situ (Phase 4)
Breast Diseases (Phase 2)
Breast Neoplasms (Phase 4)
Breast Neoplasms, Male (Phase 3)
Brenner Tumor (Phase 3)
Bronchiolitis (Phase 2)
Bronchiolitis Obliterans (Phase 2)
Burkitt Lymphoma (Phase 3)
Cachexia (Phase 3)
Calcinosis (Phase 1)
Cancer Pain (Phase 4)
Candidemia (Phase 3)
Candidiasis (Phase 3)
Candidiasis, Oral (Phase 3)
Carcinogenesis (Phase 2)
Carcinoid Tumor (Phase 3)
Carcinoma (Phase 4)
Carcinoma, Acinar Cell (Phase 3)
Carcinoma, Adenoid Cystic (Phase 2)
Carcinoma, Adenosquamous (Phase 3)
Carcinoma, Basal Cell (Phase 2)
Carcinoma, Basosquamous (Phase 2)
Carcinoma, Ductal (Phase 3)
Carcinoma, Ductal, Breast (Phase 3)
Carcinoma, Embryonal (Phase 3)
Carcinoma, Endometrioid (Phase 3)
Carcinoma, Giant Cell (Phase 2)
Carcinoma, Hepatocellular (Phase 3)
Carcinoma in Situ (Phase 3)
Carcinoma, Intraductal, Noninfiltrating (Phase 3)
Carcinoma, Islet Cell (Phase 2)
Carcinoma, Large Cell (Phase 2)
Carcinoma, Lobular (Phase 3)
Carcinoma, Medullary (Phase 2)
Carcinoma, Merkel Cell (Phase 3)
Carcinoma, Mucoepidermoid (Phase 2)
Carcinoma, Neuroendocrine (Phase 2)
Carcinoma, Non-Small-Cell Lung (Phase 3)
Carcinoma, Ovarian Epithelial (Phase 3)
Carcinoma, Pancreatic Ductal (Phase 1)
Carcinoma, Papillary (Phase 2)
Carcinoma, Renal Cell (Phase 4)
Carcinoma, Signet Ring Cell (Phase 3)
Carcinoma, Skin Appendage (Phase 2)
Carcinoma, Small Cell (Phase 3)
Carcinoma, Squamous Cell (Phase 3)
Carcinoma, Transitional Cell (Phase 3)
Carcinoma, Verrucous (Phase 3)
Carcinosarcoma (Phase 3)
Cardiomyopathies (Phase 2)
Cardiotoxicity (Phase 3)
Cardiovascular Diseases (Phase 3)
Carney Complex (Phase 2)
Carotid Body Tumor (Phase 2)
Castleman Disease (Phase 2)
Cataract (Phase 3)
Celiac Disease (Phase 1)
Central Nervous System Neoplasms (Phase 3)
Cerebrovascular Disorders (Phase 3)
Cervical Intraepithelial Neoplasia (Phase 3)
Cholangiocarcinoma (Phase 3)
Chondrosarcoma (Phase 3)
Chondrosarcoma, Clear Cell (Phase 2)
Chondrosarcoma, Mesenchymal (Phase 3)
Chordoma (Phase 2)
Choriocarcinoma (Phase 3)
Choroid Plexus Neoplasms (Phase 3)
Chronic Disease (Phase 2)
Cleft Lip (Phase 3)
Cleft Palate (Phase 3)
Cognition Disorders (Phase 2)
Cognitive Dysfunction (Phase 3)
Colitis (Phase 2)
Colitis, Ulcerative (Phase 2)
Colonic Neoplasms (Phase 3)
Colorectal Neoplasms (Phase 3)
Common Variable Immunodeficiency (Phase 2)
Communicable Diseases (Phase 4)
Conjunctival Neoplasms (Phase 2)
Constipation (Phase 3)
Coronary Artery Disease (Phase 3)
Coronary Disease (Phase 3)
Cranial Nerve Diseases (Phase 2)
Craniopharyngioma (Phase 2)
Crohn Disease (Phase 2)
Cystadenocarcinoma (Phase 3)
Cystadenocarcinoma, Mucinous (Phase 3)
Cystadenocarcinoma, Serous (Phase 3)
Cytomegalovirus Infections (Phase 3)
Deglutition Disorders (Phase 2)
Delirium (Phase 3)
Depression (Phase 4)
Depressive Disorder (Phase 4)
Depressive Disorder, Major (Phase 4)
Dermatitis (Phase 3)
Dermatitis, Atopic (Phase 2)
Dermatitis, Phototoxic (Phase 1)
Dermatofibrosarcoma (Phase 3)
Dermatomyositis (Phase 1)
Desmoplastic Small Round Cell Tumor (Phase 2)
Diabetes Mellitus (Phase 3)
Diarrhea (Phase 3)
Digestive System Diseases (Phase 3)
Digestive System Neoplasms (Phase 2)
Disease (Phase 3)
Disease Progression (Phase 2)
Disease Susceptibility (Phase 2)
DNA Repair-Deficiency Disorders (Phase 2)
Down Syndrome (Phase 3)
Drug Resistant Epilepsy (Phase 4)
Dysgerminoma (Phase 2)
Dysgeusia (Phase 3)
Dysplastic Nevus Syndrome (Phase 2)
Dyspnea (Phase 3)
Eclampsia (Phase 3)
Embolism (Phase 3)
Emergencies (Phase 1)
Encephalitis (Phase 2)
Endocrine Gland Neoplasms (Phase 2)
Endodermal Sinus Tumor (Phase 3)
Endometrial Hyperplasia (Phase 2)
Endometrial Neoplasms (Phase 3)
Enteritis (Phase 3)
Enteropathy-Associated T-Cell Lymphoma (Phase 2)
Ependymoma (Phase 3)
Epilepsies, Partial (Phase 4)
Epilepsy (Phase 4)
Epstein-Barr Virus Infections (Phase 3)
Erdheim-Chester Disease (Phase 2)
Erectile Dysfunction (Phase 3)
Esophageal Neoplasms (Phase 4)
Esophageal Squamous Cell Carcinoma (Phase 3)
Esophagitis (Phase 2)
Esthesioneuroblastoma, Olfactory (Phase 2)
Exanthema (Phase 1)
Eye Neoplasms (Phase 3)
Fallopian Tube Neoplasms (Phase 3)
Fanconi Anemia (Phase 2)
Fanconi Syndrome (Phase 2)
Fasciitis (Phase 2)
Fatigue (Phase 4)
Fatty Liver (Phase 2)
Febrile Neutropenia (Phase 1)
Fever (Phase 3)
Fibrocystic Breast Disease (Phase 2)
Fibroma (Phase 3)
Fibromatosis, Aggressive (Phase 3)
Fibrosarcoma (Phase 3)
Fibrosis (Phase 3)
Fowlpox (Phase 2)
Fungemia (Phase 3)
Gallbladder Neoplasms (Phase 3)
Ganglioglioma (Phase 2)
Ganglioneuroblastoma (Phase 3)
Ganglioneuroma (Phase 1)
Gastrinoma (Phase 2)
Gastritis (Phase 2)
Gastritis, Atrophic (Phase 2)
Gastritis, Hypertrophic (Phase 1)
Gastrointestinal Diseases (Phase 3)
Gastrointestinal Hemorrhage (Phase 2)
Gastrointestinal Neoplasms (Phase 3)
Gastrointestinal Stromal Tumors (Phase 3)
Genetic Diseases, Inborn (Phase 2)
Genetic Predisposition to Disease (Phase 2)
Genital Neoplasms, Female (Phase 4)
Genomic Instability (Phase 2)
Germinoma (Phase 3)
Gestational Trophoblastic Disease (Phase 3)
Glioblastoma (Phase 3)
Glioma (Phase 4)
Glioma, Subependymal (Phase 1)
Gliosarcoma (Phase 3)
Glomus Tumor (Phase 3)
Glucagonoma (Phase 2)
Gonadal Disorders (Phase 2)
Graft vs Host Disease (Phase 3)
Granular Cell Tumor (Phase 3)
Granuloma (Phase 2)
Granulomatous Disease, Chronic (Phase 2)
Granulosa Cell Tumor (Phase 2)
Hamartoma (Phase 2)
Hamartoma Syndrome, Multiple (Phase 2)
Hand-Foot Syndrome (Phase 3)
Head and Neck Neoplasms (Phase 3)
Heart Diseases (Phase 3)
Heart Failure (Phase 2)
HELLP Syndrome (Phase 3)
Hemangioendothelioma (Phase 2)
Hemangioendothelioma, Epithelioid (Phase 2)
Hemangiopericytoma (Phase 3)
Hemangiosarcoma (Phase 3)
Hematologic Diseases (Phase 3)
Hematologic Neoplasms (Phase 2)
Hemoglobinuria (Phase 2)
Hemoglobinuria, Paroxysmal (Phase 2)
Hemolysis (Phase 2)
Hemoptysis (Phase 2)
Hemorrhage (Phase 2)
Hepatitis (Phase 4)
Hepatitis A (Phase 4)
Hepatitis B (Phase 3)
Hepatitis C (Phase 4)
Hepatitis C, Chronic (Phase 3)
Hepatitis, Chronic (Phase 1)
Hepatoblastoma (Phase 3)
Hepatomegaly (Phase 2)
Herpes Simplex (Phase 3)
Histiocytic Sarcoma (Phase 2)
Histiocytoma (Phase 3)
Histiocytoma, Benign Fibrous (Phase 3)
Histiocytoma, Malignant Fibrous (Phase 3)
Histiocytosis (Phase 2)
Histiocytosis, Langerhans-Cell (Phase 2)
HIV Infections (Phase 4)
HIV Seropositivity (Phase 2)
Hodgkin Disease (Phase 3)
Hot Flashes (Phase 3)
HTLV-I Infections (Phase 2)
Hutchinson's Melanotic Freckle (Phase 2)
Hydatidiform Mole (Phase 3)
Hypercalcemia (Phase 3)
Hypereosinophilic Syndrome (Phase 3)
Hyperglycemia (Phase 3)
Hyperplasia (Phase 3)
Hypersensitivity (Phase 3)
Hypertension (Phase 2)
Hypopharyngeal Neoplasms (Phase 2)
Hypoxia (Phase 2)
Ichthyosis (Phase 1)
IgA Deficiency (Phase 1)
Immune System Diseases (Phase 3)
Immunoblastic Lymphadenopathy (Phase 2)
Immunoglobulin Light-chain Amyloidosis (Phase 3)
Immunologic Deficiency Syndromes (Phase 3)
Infarction (Phase 3)
Infections (Phase 4)
Infertility (Phase 3)
Inflammation (Phase 2)
Inflammatory Bowel Diseases (Phase 1)
Inflammatory Breast Neoplasms (Phase 3)
Insulinoma (Phase 2)
Intestinal Diseases (Phase 2)
Intestinal Neoplasms (Phase 3)
Intestinal Obstruction (Phase 3)
Intraocular Lymphoma (Phase 2)
Invasive Fungal Infections (Phase 3)
Ischemia (Phase 3)
Keratoacanthoma (Phase 2)
Keratosis (Phase 3)
Keratosis, Actinic (Phase 3)
Kidney Diseases (Phase 2)
Kidney Failure, Chronic (Phase 3)
Kidney Neoplasms (Phase 4)
Klatskin Tumor (Phase 2)
Laboratory Infection (Phase 2)
Lambert-Eaton Myasthenic Syndrome (Phase 2)
Laryngeal Diseases (Phase 3)
Laryngeal Neoplasms (Phase 3)
Leiomyoma (Phase 2)
Leiomyomatosis (Phase 2)
Leiomyosarcoma (Phase 3)
Lentigo (Phase 2)
Leukemia (Phase 3)
Leukemia, Basophilic, Acute (Phase 3)
Leukemia, B-Cell (Phase 3)
Leukemia, Biphenotypic, Acute (Phase 3)
Leukemia, Eosinophilic, Acute (Phase 3)
Leukemia, Erythroblastic, Acute (Phase 3)
Leukemia, Hairy Cell (Phase 2)
Leukemia, Large Granular Lymphocytic (Phase 2)
Leukemia, Lymphocytic, Chronic, B-Cell (Phase 3)
Leukemia, Lymphoid (Phase 4)
Leukemia-Lymphoma, Adult T-Cell (Phase 2)
Leukemia, Mast-Cell (Phase 2)
Leukemia, Megakaryoblastic, Acute (Phase 3)
Leukemia, Monocytic, Acute (Phase 3)
Leukemia, Myeloid (Phase 3)
Leukemia, Myeloid, Accelerated Phase (Phase 2)
Leukemia, Myeloid, Acute (Phase 3)
Leukemia, Myeloid, Chronic-Phase (Phase 3)
Leukemia, Myelomonocytic, Acute (Phase 3)
Leukemia, Myelomonocytic, Chronic (Phase 3)
Leukemia, Myelomonocytic, Juvenile (Phase 3)
Leukemia, Neutrophilic, Chronic (Phase 3)
Leukemia, Plasma Cell (Phase 2)
Leukemia, Prolymphocytic (Phase 3)
Leukemia, Prolymphocytic, B-Cell (Phase 2)
Leukemia, Prolymphocytic, T-Cell (Phase 2)
Leukemia, Promyelocytic, Acute (Phase 3)
Leukemia, T-Cell (Phase 2)
Leukemoid Reaction (Phase 3)
Leukoplakia (Phase 2)
Leukoplakia, Oral (Phase 2)
Leydig Cell Tumor (Phase 2)
Li-Fraumeni Syndrome (Phase 1)
Lip Neoplasms (Phase 3)
Liposarcoma (Phase 3)
Liposarcoma, Myxoid (Phase 2)
Liver Cirrhosis (Phase 3)
Liver Diseases (Phase 2)
Liver Failure (Phase 1)
Liver Neoplasms (Phase 4)
Liver Neoplasms, Experimental (Phase 2)
Lung Diseases (Phase 2)
Lung Diseases, Obstructive (Phase 3)
Lung Injury (Phase 2)
Lung Neoplasms (Phase 4)
Lupus Erythematosus, Discoid (Phase 2)
Lupus Erythematosus, Systemic (Phase 2)
Lymphadenopathy (Phase 2)
Lymphedema (Phase 3)
Lymphocytosis (Phase 2)
Lymphohistiocytosis, Hemophagocytic (Phase 2)
Lymphoma (Phase 4)
Lymphoma, AIDS-Related (Phase 2)
Lymphoma, B-Cell (Phase 3)
Lymphoma, B-Cell, Marginal Zone (Phase 2)
Lymphoma, Extranodal NK-T-Cell (Phase 2)
Lymphoma, Follicular (Phase 3)
Lymphoma, Large B-Cell, Diffuse (Phase 3)
Lymphoma, Large-Cell, Anaplastic (Phase 3)
Lymphoma, Large-Cell, Immunoblastic (Phase 3)
Lymphoma, Mantle-Cell (Phase 3)
Lymphoma, Non-Hodgkin (Phase 3)
Lymphoma, Primary Effusion (Phase 2)
Lymphoma, T-Cell (Phase 4)
Lymphoma, T-Cell, Cutaneous (Phase 4)
Lymphoma, T-Cell, Peripheral (Phase 2)
Lymphomatoid Granulomatosis (Phase 2)
Lymphomatoid Papulosis (Phase 2)
Lymphopenia (Phase 1)
Lymphoproliferative Disorders (Phase 3)
Macroglossia (Phase 2)
Macular Degeneration (Phase 3)
Malaria (Phase 1)
Malignant Carcinoid Syndrome (Phase 3)
Mastocytosis (Phase 2)
Mastocytosis, Systemic (Phase 2)
Medulloblastoma (Phase 3)
Melanoma (Phase 3)
Melanoma, Experimental (Phase 2)
Melanosis (Phase 3)
Meningeal Carcinomatosis (Phase 2)
Meningeal Neoplasms (Phase 2)
Meningioma (Phase 3)
Meningitis (Phase 1)
Mesenchymoma (Phase 3)
Mesothelioma (Phase 3)
Metaplasia (Phase 2)
Microsatellite Instability (Phase 2)
Mixed Tumor, Mullerian (Phase 3)
Monosomy (Phase 2)
Mouth Neoplasms (Phase 3)
Mucositis (Phase 3)
Multiple Endocrine Neoplasia (Phase 2)
Multiple Endocrine Neoplasia Type 1 (Phase 2)
Multiple Endocrine Neoplasia Type 2a (Phase 2)
Multiple Endocrine Neoplasia Type 2b (Phase 2)
Multiple Myeloma (Phase 3)
Multiple Pulmonary Nodules (Phase 2)
Multiple Sclerosis (Phase 2)
Muscle Weakness (Phase 2)
Myasthenia Gravis (Phase 2)
Mycobacterium Infections (Phase 1)
Mycoses (Phase 3)
Mycosis Fungoides (Phase 2)
Myelodysplastic Syndromes (Phase 3)
Myeloproliferative Disorders (Phase 3)
Myocardial Infarction (Phase 3)
Myocardial Ischemia (Phase 3)
Myoclonus (Phase 2)
Myofibroma (Phase 2)
Nasopharyngeal Carcinoma (Phase 3)
Nasopharyngeal Neoplasms (Phase 2)
Nausea (Phase 3)
Necrosis (Phase 3)
Neoplasm Metastasis (Phase 3)
Neoplasm Micrometastasis (Phase 1)
Neoplasm, Residual (Phase 3)
Neoplasms (Phase 4)
Neoplasms, Experimental (Phase 2)
Neoplasms, Germ Cell and Embryonal (Phase 3)
Neoplasms, Glandular and Epithelial (Phase 1)
Neoplasms, Nerve Tissue (Phase 2)
Neoplasms, Neuroepithelial (Phase 2)
Neoplasms, Plasma Cell (Phase 3)
Neoplasms, Second Primary (Phase 3)
Neoplasms, Squamous Cell (Phase 2)
Neoplasms, Unknown Primary (Phase 2)
Neoplastic Cells, Circulating (Phase 2)
Neoplastic Processes (Phase 2)
Neoplastic Syndromes, Hereditary (Phase 2)
Nerve Sheath Neoplasms (Phase 3)
Nervous System Diseases (Phase 2)
Nervous System Neoplasms (Phase 3)
Neuralgia (Phase 3)
Neurilemmoma (Phase 2)
Neuroblastoma (Phase 3)
Neuroectodermal Tumors (Phase 3)
Neuroectodermal Tumors, Primitive (Phase 3)
Neuroendocrine Tumors (Phase 3)
Neurofibroma (Phase 3)
Neurofibroma, Plexiform (Phase 2)
Neurofibromatoses (Phase 3)
Neurofibromatosis 1 (Phase 3)
Neurofibromatosis 2 (Phase 2)
Neurofibrosarcoma (Phase 3)
Neuroma, Acoustic (Phase 2)
Neuromyelitis Optica (Phase 2)
Neurotoxicity Syndromes (Phase 3)
Neutropenia (Phase 3)
Non-alcoholic Fatty Liver Disease (Phase 2)
Ocular Motility Disorders (Phase 2)
Oligodendroglioma (Phase 3)
Opioid-Related Disorders (Phase 4)
Opsoclonus-Myoclonus Syndrome (Phase 2)
Optic Nerve Glioma (Phase 2)
Oropharyngeal Neoplasms (Phase 3)
Osteonecrosis (Phase 2)
Osteoporosis (Phase 3)
Osteosarcoma (Phase 3)
Ovarian Neoplasms (Phase 3)
Paget Disease, Extramammary (Phase 2)
Paget's Disease, Mammary (Phase 2)
Pain, Postoperative (Phase 3)
Pancoast Syndrome (Phase 2)
Pancreatic Intraductal Neoplasms (Phase 3)
Pancreatic Neoplasms (Phase 4)
Pancreatitis (Phase 2)
Pancytopenia (Phase 2)
Panniculitis (Phase 2)
Papilloma (Phase 3)
Papilloma, Inverted (Phase 2)
Papillomavirus Infections (Phase 4)
Paraganglioma (Phase 2)
Paraganglioma, Extra-Adrenal (Phase 2)
Paranasal Sinus Neoplasms (Phase 2)
Paraproteinemias (Phase 2)
Parasomnias (Phase 3)
Parathyroid Neoplasms (Phase 1)
Paresis (Phase 2)
Pelvic Neoplasms (Phase 3)
Penile Neoplasms (Phase 2)
Pericardial Effusion (Phase 2)
Periodontal Diseases (Phase 2)
Peripheral Nervous System Diseases (Phase 3)
Peritoneal Neoplasms (Phase 3)
Pharyngeal Neoplasms (Phase 1)
Pheochromocytoma (Phase 2)
Philadelphia Chromosome (Phase 3)
Pinealoma (Phase 3)
Pituitary ACTH Hypersecretion (Phase 2)
Pituitary Diseases (Phase 2)
Pituitary Neoplasms (Phase 2)
Plasmablastic Lymphoma (Phase 3)
Plasmacytoma (Phase 3)
Pleural Diseases (Phase 1)
Pleural Effusion (Phase 3)
Pleural Effusion, Malignant (Phase 3)
Pneumonia (Phase 3)
POEMS Syndrome (Phase 2)
Poisoning (Phase 3)
Polycythemia (Phase 3)
Polycythemia Vera (Phase 3)
Polyneuropathies (Phase 2)
Polyomavirus Infections (Phase 2)
Polyps (Phase 3)
Postoperative Complications (Phase 3)
Precancerous Conditions (Phase 3)
Pre-Eclampsia (Phase 3)
Preleukemia (Phase 3)
Primary Myelofibrosis (Phase 3)
Prolactinoma (Phase 1)
Prostatic Hyperplasia (Phase 2)
Prostatic Intraepithelial Neoplasia (Phase 3)
Prostatic Neoplasms (Phase 4)
Protein Deficiency (Phase 2)
Pseudomyxoma Peritonei (Phase 2)
Psoriasis (Phase 2)
Pulmonary Blastoma (Phase 2)
Pulmonary Disease, Chronic Obstructive (Phase 3)
Pulmonary Embolism (Phase 3)
Purpura (Phase 2)
Purpura, Thrombocytopenic (Phase 1)
Purpura, Thrombocytopenic, Idiopathic (Phase 1)
Radiation Injuries (Phase 2)
Radiation Pneumonitis (Phase 2)
Radiodermatitis (Phase 3)
Rectal Neoplasms (Phase 3)
Recurrence (Phase 4)
Red-Cell Aplasia, Pure (Phase 2)
Renal Insufficiency (Phase 1)
Respiratory Distress Syndrome (Phase 1)
Respiratory Distress Syndrome, Newborn (Phase 1)
Respiratory Tract Infections (Phase 3)
Retinal Neoplasms (Phase 3)
Retinoblastoma (Phase 3)
Retroperitoneal Neoplasms (Phase 1)
Rhabdoid Tumor (Phase 3)
Rhabdomyosarcoma (Phase 3)
Rhabdomyosarcoma, Alveolar (Phase 3)
Rhabdomyosarcoma, Embryonal (Phase 3)
Salivary Gland Neoplasms (Phase 3)
Sarcoma (Phase 3)
Sarcoma, Alveolar Soft Part (Phase 3)
Sarcoma, Clear Cell (Phase 3)
Sarcoma, Endometrial Stromal (Phase 2)
Sarcoma, Ewing (Phase 3)
Sarcoma, Kaposi (Phase 3)
Sarcoma, Myeloid (Phase 3)
Sarcoma, Synovial (Phase 3)
Schizophrenia (Phase 1)
Scleroderma, Diffuse (Phase 2)
Scleroderma, Systemic (Phase 2)
Sclerosis (Phase 3)
Seizures (Phase 4)
Seminoma (Phase 3)
Sepsis (Phase 2)
Serotonin Syndrome (Phase 2)
Sertoli Cell Tumor (Phase 2)
Sertoli-Leydig Cell Tumor (Phase 2)
Severe Combined Immunodeficiency (Phase 1)
Sex Cord-Gonadal Stromal Tumors (Phase 2)
Sexually Transmitted Diseases (Phase 4)
Sezary Syndrome (Phase 2)
Sjogren's Syndrome (Phase 1)
Skin Diseases (Phase 3)
Skin Diseases, Genetic (Phase 2)
Skin Neoplasms (Phase 3)
Sleepiness (Phase 2)
Sleep Wake Disorders (Phase 3)
Small Cell Lung Carcinoma (Phase 3)
Smoldering Multiple Myeloma (Phase 3)
Soft Tissue Neoplasms (Phase 3)
Solitary Pulmonary Nodule (Phase 2)
Somatostatinoma (Phase 2)
Spinal Cord Neoplasms (Phase 3)
Squamous Cell Carcinoma of Head and Neck (Phase 3)
Staphylococcal Infections (Phase 3)
Stiff-Person Syndrome (Phase 2)
Stomach Neoplasms (Phase 4)
Stomatitis (Phase 3)
Stress, Psychological (Phase 1)
Stroke (Phase 3)
Sweat Gland Neoplasms (Phase 2)
Syndrome (Phase 3)
Teratoma (Phase 3)
Testicular Diseases (Phase 2)
Testicular Neoplasms (Phase 3)
Tetanus (Phase 2)
Thalassemia (Phase 2)
Thrombasthenia (Phase 2)
Thrombocythemia, Essential (Phase 3)
Thrombocytopenia (Phase 2)
Thrombocytosis (Phase 3)
Thromboembolism (Phase 3)
Thrombosis (Phase 3)
Thymoma (Phase 2)
Thymus Neoplasms (Phase 2)
Thyroid Cancer, Papillary (Phase 2)
Thyroid Carcinoma, Anaplastic (Phase 2)
Thyroid Diseases (Phase 2)
Thyroid Neoplasms (Phase 2)
Tissue Adhesions (Phase 2)
Tobacco Use Disorder (Phase 4)
Tongue Neoplasms (Phase 3)
Triple Negative Breast Neoplasms (Phase 3)
Trophoblastic Neoplasms (Phase 3)
Ulcer (Phase 1)
Unconsciousness (Phase 2)
Unilateral Breast Neoplasms (Phase 2)
Ureteral Neoplasms (Phase 3)
Urethral Neoplasms (Phase 3)
Urinary Bladder Neoplasms (Phase 4)
Urogenital Neoplasms (Phase 2)
Uterine Cervical Neoplasms (Phase 4)
Uterine Neoplasms (Phase 2)
Uveal Neoplasms (Phase 3)
Vaccinia (Phase 2)
Vaginal Neoplasms (Phase 3)
Vascular Diseases (Phase 3)
Vasculitis (Phase 2)
Vasculitis, Central Nervous System (Phase 2)
Venous Thromboembolism (Phase 3)
Venous Thrombosis (Phase 3)
Ventricular Remodeling (Phase 2)
Vipoma (Phase 2)
Viremia (Phase 2)
Virus Diseases (Phase 3)
Vitamin D Deficiency (Phase 2)
Vomiting (Phase 3)
von Hippel-Lindau Disease (Phase 2)
Vulvar Diseases (Phase 1)
Vulvar Neoplasms (Phase 3)
Waldenstrom Macroglobulinemia (Phase 3)
Wasting Syndrome (Phase 3)
Weight Loss (Phase 3)
Wilms Tumor (Phase 3)
Wiskott-Aldrich Syndrome (Phase 2)
Wounds and Injuries (Phase 2)
Xanthogranuloma, Juvenile (Phase 2)
Xeroderma Pigmentosum (Phase 1)
Xerostomia (Phase 3)
Zollinger-Ellison Syndrome (Phase 1)